RESTYLANE INJECTABLE GEL
FDA premarket approval P040024/S018 · decided 2008-08-06
Approval details
- PMA number
- P040024
- Supplement
- S018
- Supplement type
- 135 Review Track For 30-Day Notice
- Trade name
- RESTYLANE INJECTABLE GEL
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2008-02-07
- Decision date
- 2008-08-06
- Days to decision
- 181 days
- Decision code
- APPR
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- APPROVAL FOR A CHANGE IN TEST METHOD FOR HYALURONIC ACID AND GEL CONTENT USED IN THE MANUFACTURING OF THE DEVICE.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.